Skip to main content

Table 1 Available diagnostic information for all AD cases

From: Combination of snapshot hyperspectral retinal imaging and optical coherence tomography to identify Alzheimer’s disease patients

AD subject Age (years) MMSE Neuropsychol. assessment Structural MRI FDG PET Amyloid-PET CSF Duration of follow-up (years)
1 82 15 + +/− 10.5
2 69 18 + + 1
3 63 22 + + 2
4 67 27 + + 4.5
5 62 ≤ 8* + +/− + + 3.5
6 73 17 + + 1.5
7 74 10 + + 2
8 76 14 + 1
9 71 15 + + + + 7
10 81 17 + + 6
11 79 22 + + + + 1
12 77 20 + +/− +/− + 4
13 72 22 + + + 3.5
14 70 14 + + + 1.5
15 73 24 + + 1.5
16 75 24 + + + + 5
17 58 10 + + + 1.5
  1. MMSE Mini-Mental State Examination score at the time of testing, Neuropsychol. assessment neuropsychological assessment as part of the diagnostic workup, + performed and in accordance with an AD diagnosis, − not done, +/− performed but not contributive. APOE genotypes are not provided for confidentiality reasons
  2. *MMSE no longer possible at the time of ocular imaging; noted score is the latest available one